A detailed history of Meritage Portfolio Management transactions in Amgen Inc stock. As of the latest transaction made, Meritage Portfolio Management holds 25,180 shares of AMGN stock, worth $7.96 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
25,180
Previous 25,490 1.22%
Holding current value
$7.96 Million
Previous $7.25 Million 8.56%
% of portfolio
0.5%
Previous 0.46%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$262.75 - $319.31 $81,452 - $98,986
-310 Reduced 1.22%
25,180 $7.87 Million
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $444,173 - $536,173
-1,652 Reduced 6.09%
25,490 $7.25 Million
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $379,458 - $428,074
1,484 Added 5.78%
27,142 $7.82 Million
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $160,270 - $198,980
-733 Reduced 2.78%
25,658 $6.9 Million
Q2 2023

Jul 31, 2023

SELL
$214.27 - $253.37 $358,045 - $423,381
-1,671 Reduced 5.95%
26,391 $5.86 Million
Q1 2023

Apr 25, 2023

BUY
$225.79 - $275.2 $7,902 - $9,632
35 Added 0.12%
28,062 $6.78 Million
Q4 2022

Feb 01, 2023

SELL
$229.03 - $291.01 $70,541 - $89,631
-308 Reduced 1.09%
28,027 $7.36 Million
Q3 2022

Oct 25, 2022

SELL
$224.46 - $253.15 $218,848 - $246,821
-975 Reduced 3.33%
28,335 $6.39 Million
Q2 2022

Jul 25, 2022

BUY
$230.71 - $256.74 $6.76 Million - $7.53 Million
29,310 New
29,310 $7.13 Million
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $2.33 Million - $2.72 Million
-10,955 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $16,117 - $17,880
69 Added 0.63%
10,955 $2.67 Million
Q1 2021

Apr 27, 2021

BUY
$221.91 - $258.6 $2.42 Million - $2.82 Million
10,886 New
10,886 $2.71 Million
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $1.94 Million - $2.31 Million
-8,961 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$234.65 - $260.95 $193,586 - $215,283
-825 Reduced 8.43%
8,961 $2.28 Million
Q2 2020

Jul 27, 2020

SELL
$197.81 - $242.74 $199,788 - $245,167
-1,010 Reduced 9.36%
9,786 $2.31 Million
Q1 2020

Apr 27, 2020

SELL
$182.24 - $241.7 $6.03 Million - $8 Million
-33,096 Reduced 75.4%
10,796 $2.19 Million
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $27,813 - $35,750
-147 Reduced 0.33%
43,892 $10.6 Million
Q3 2019

Oct 25, 2019

BUY
$174.11 - $208.62 $4.45 Million - $5.33 Million
25,561 Added 138.33%
44,039 $8.52 Million
Q2 2019

Jul 30, 2019

BUY
$166.7 - $195.41 $3.08 Million - $3.61 Million
18,478 New
18,478 $3.41 Million
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $7.78 Million - $8.77 Million
-42,995 Closed
0 $0
Q4 2018

Jan 25, 2019

SELL
$178.4 - $208.25 $204,624 - $238,862
-1,147 Reduced 2.6%
42,995 $8.37 Million
Q3 2018

Oct 30, 2018

SELL
$185.29 - $208.89 $65,222 - $73,529
-352 Reduced 0.79%
44,142 $9.15 Million
Q2 2018

Jul 25, 2018

SELL
$166.05 - $186.51 $62,766 - $70,500
-378 Reduced 0.84%
44,494 $8.21 Million
Q1 2018

Apr 26, 2018

BUY
$169.43 - $198.0 $151,978 - $177,606
897 Added 2.04%
44,872 $7.65 Million
Q4 2017

Jan 29, 2018

SELL
$168.79 - $188.59 $117,477 - $131,258
-696 Reduced 1.56%
43,975 $7.65 Million
Q3 2017

Oct 16, 2017

BUY
$167.29 - $191.0 $7.47 Million - $8.53 Million
44,671
44,671 $8.33 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Meritage Portfolio Management Portfolio

Follow Meritage Portfolio Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.